| Full Name | Ernest M Bove |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 43 Years |
| Location | 145 Allen St, Rutland, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649245382 | NPI | - | NPPES |
| 42007313 | Other | VT | VT LICENSE |
| 42007313 | Medicaid | VT | |
| 0006431 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 42007313 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rutland Regional Medical Center | Rutland, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rutland Hospital Inc | 7214846377 | 157 |
News Archive
EKF Diagnostics the global in vitro diagnostics company, announces that it has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range.
Results of a new double-blind, placebo-controlled human clinical trial found that daily supplementation with chromium picolinate significantly reduced some key symptoms of atypical depression.
A new study shows that genetic pre-screening could reduce the number of screening tests needed to identify individuals at risk for osteoporotic fractures. Douglas P. Kiel, M.D., M.P.H., director of the Musculoskeletal Research Center in the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife, is an author on the report published this month in PLOS (Public Library of Science) Medicine.
Chelsea Therapeutics International, Ltd. announced that preliminary analyses of its Phase III NORTHERA™ Study 301 met its primary endpoint. Treatment with Northera provided clinically meaningful and statistically significant improvement.
› Verified 1 days ago
| Entity Name | Rutland Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083678833 PECOS PAC ID: 7214846377 Enrollment ID: O20040913000323 |
News Archive
EKF Diagnostics the global in vitro diagnostics company, announces that it has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range.
Results of a new double-blind, placebo-controlled human clinical trial found that daily supplementation with chromium picolinate significantly reduced some key symptoms of atypical depression.
A new study shows that genetic pre-screening could reduce the number of screening tests needed to identify individuals at risk for osteoporotic fractures. Douglas P. Kiel, M.D., M.P.H., director of the Musculoskeletal Research Center in the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife, is an author on the report published this month in PLOS (Public Library of Science) Medicine.
Chelsea Therapeutics International, Ltd. announced that preliminary analyses of its Phase III NORTHERA™ Study 301 met its primary endpoint. Treatment with Northera provided clinically meaningful and statistically significant improvement.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ernest M Bove, MD Po Box 666, Rutland, VT 05702 Ph: (802) 775-6006 | Ernest M Bove, MD 145 Allen St, Rutland, VT 05701 Ph: (802) 775-6006 |
News Archive
EKF Diagnostics the global in vitro diagnostics company, announces that it has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range.
Results of a new double-blind, placebo-controlled human clinical trial found that daily supplementation with chromium picolinate significantly reduced some key symptoms of atypical depression.
A new study shows that genetic pre-screening could reduce the number of screening tests needed to identify individuals at risk for osteoporotic fractures. Douglas P. Kiel, M.D., M.P.H., director of the Musculoskeletal Research Center in the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife, is an author on the report published this month in PLOS (Public Library of Science) Medicine.
Chelsea Therapeutics International, Ltd. announced that preliminary analyses of its Phase III NORTHERA™ Study 301 met its primary endpoint. Treatment with Northera provided clinically meaningful and statistically significant improvement.
› Verified 1 days ago
Zita Ficko, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 145 Allen St, Rutland, VT 05701 Phone: 802-775-6006 Fax: 802-773-4946 |